Literature DB >> 33338398

Therapeutic Targeting of PTEN in Duchenne Muscular Dystrophy.

Arshiya Parveen1, Yefei Wen1, Anirban Roy1, Ashok Kumar2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33338398      PMCID： PMC7791074          DOI： 10.1016/j.ymthe.2020.12.014

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  10 in total

Review 1.  The functions and regulation of the PTEN tumour suppressor: new modes and prospects.

Authors:  Yu-Ru Lee; Ming Chen; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2018-09       Impact factor: 94.444

2.  Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.

Authors:  Natassia M Vieira; Janelle M Spinazzola; Matthew S Alexander; Yuri B Moreira; Genri Kawahara; Devin E Gibbs; Lillian C Mead; Sergio Verjovski-Almeida; Mayana Zatz; Louis M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

3.  Conditional Loss of Pten in Myogenic Progenitors Leads to Postnatal Skeletal Muscle Hypertrophy but Age-Dependent Exhaustion of Satellite Cells.

Authors:  Feng Yue; Pengpeng Bi; Chao Wang; Jie Li; Xiaoqi Liu; Shihuan Kuang
Journal:  Cell Rep       Date:  2016-11-22       Impact factor: 9.423

4.  Muscle-specific expression of the RNA-binding protein Staufen1 induces progressive skeletal muscle atrophy via regulation of phosphatase tensin homolog.

Authors:  Tara E Crawford Parks; Aymeric Ravel-Chapuis; Emma Bondy-Chorney; Jean-Marc Renaud; Jocelyn Côté; Bernard J Jasmin
Journal:  Hum Mol Genet       Date:  2017-05-15       Impact factor: 6.150

5.  MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms.

Authors:  Matthew S Alexander; Juan Carlos Casar; Norio Motohashi; Natássia M Vieira; Iris Eisenberg; Jamie L Marshall; Molly J Gasperini; Angela Lek; Jennifer A Myers; Elicia A Estrella; Peter B Kang; Frederic Shapiro; Fedik Rahimov; Genri Kawahara; Jeffrey J Widrick; Louis M Kunkel
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

Review 6.  The muscular dystrophies.

Authors:  Alan E H Emery
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321

7.  Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice.

Authors:  Michelle H Kim; Danielle I Kay; Renuka T Rudra; Bo Ming Chen; Nigel Hsu; Yasuhiro Izumiya; Leonel Martinez; Melissa J Spencer; Kenneth Walsh; Alan D Grinnell; Rachelle H Crosbie
Journal:  Hum Mol Genet       Date:  2011-01-18       Impact factor: 6.150

8.  PTEN Inhibition Ameliorates Muscle Degeneration and Improves Muscle Function in a Mouse Model of Duchenne Muscular Dystrophy.

Authors:  Feng Yue; Changyou Song; Di Huang; Naagarajan Narayanan; Jiamin Qiu; Zhihao Jia; Zhengrong Yuan; Stephanie N Oprescu; Bruno T Roseguini; Meng Deng; Shihuan Kuang
Journal:  Mol Ther       Date:  2020-09-23       Impact factor: 11.454

Review 9.  Signaling pathways controlling skeletal muscle mass.

Authors:  Marc A Egerman; David J Glass
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-11-18       Impact factor: 8.250

10.  Polymeric nanoparticles functionalized with muscle-homing peptides for targeted delivery of phosphatase and tensin homolog inhibitor to skeletal muscle.

Authors:  Di Huang; Feng Yue; Jiamin Qiu; Meng Deng; Shihuan Kuang
Journal:  Acta Biomater       Date:  2020-10-11       Impact factor: 8.947
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.